一本关于瘤微环境对细胞组成遗传影响的图谱
Yimin Cai1, Zequn Lu1, Can Chen1
1Department of Epidemiology and Biostatistics, School of Public Health, Research Center of Public Health, Renmin hospital of Wuhan University, Department of Gastrointestinal Oncology, Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
Nature immunology
|September 2, 2024
概括
这项研究确定了数千种影响瘤微环境 (TME) 的遗传变异,并制定了结直肠癌 (CRC) 的风险评分. 一种特定的变异 (rs1360948) 通过招募调节性T细胞来影响TME,提供新的治疗点.
科学领域:
- 免疫基因组学是什么
- 癌症生物学 癌症生物学
- 计算生物学 计算生物学
背景情况:
- 了解瘤微环境 (TME) 对癌症研究和免疫疗法开发至关重要.
- 遗传变异可以显著影响TME的细胞组成.
- 癌症基因组图谱 (TCGA) 为研究癌症基因组学提供了丰富的资源.
研究的目的:
- 在各种癌症类型中绘制TME细胞类型比例的遗传影响.
- 为了确定基因位置 (免疫QTLs) 和调节TME组成的基因.
- 评估免疫QTLs在结直肠癌 (CRC) 风险分层中的实用性,并探索治疗点.
主要方法:
- 利用来自TCGA的单细胞和大量RNA测序数据.
- 确定了3,494个免疫定量特征位点 (免疫QTL) 和1,668个调节基因.
- 整合欧洲和中国的CRC数据,创建一个联合的免疫QTL地图.
- 通过使用免疫QTL和GWAS数据,开发并验证了CRC的多基因风险评分.
- 研究了immunQTL rs1360948在CRC进展和对治疗的反应中的功能作用.
主要成果:
- 在23种癌症类型中发现了3,494个免疫QTL和1,668个调节TME组成的基因.
- 结合免疫QTLs的多基因风险评分改善了大型多民族队列中的CRC风险分层.
- 免疫QTL rs1360948与CRC风险和预后有显著关联.
- rs1360948-G等位基因增加了CCL2表达,促进了调控性T细胞透和CRC中的免疫抑制.
- 阻断CCL2-CCR2通路增强了抗编程细胞死亡蛋白1配体治疗的疗效.
结论:
- 遗传因素在各种癌症中塑造TME方面发挥着重要作用.
- 免疫QTL为CRC风险分层和预后提供了有价值的生物标志物.
- 针对CCL2-CCR2轴是一个有希望的策略,以克服CRC的免疫疗法耐药性.
- 癌症免疫QTL2数据库为推进癌症免疫基因组研究提供了一个资源.
更多相关视频
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K